Central Role for Disabled-2 in Mesenchymal Stem Cardiac Protein Expression and Functional Consequences After Engraftment in Acute Myocardial Infarction
Authors:
- 28 July 2010
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 20 (4) , 681-693
Abstract
Adult mesenchymal stem cells (MSCs) have been shown to spontaneously express cardiac proteins (CP) in vitro and to improve cardiac function after transplantation into experimentally induced acute myocardial infarction (AMI). However, if these effects are the result of MSC cardiac differentiation or a mere cooperative cellular interaction is a matter of active debate. Additionally, the molecular mechanisms involved in CP expression by adult stem cells in vitro and its possible benefit for cardiac regeneration and improved function remain unclear. Here we show that although MSCs effectively engraft in AMI tissue, this engraftment leads to downregulation of CP expression in the implanted MSCs. We also found that pretransplantation cardiac specification of MSCs by exposure of the cells to transforming growth factor beta 1 (TGF-β1) led to sustained MSC CP expression without altering engraftment efficiency. This increase in CP expression was associated with greater improvement in cardiac function 1 and 4 weeks after AMI with TGF-β1-pretreated MSCs. We discovered that the TGF-β1-enhanced cardiac potential of MSCs was mediated by downregulation of disabled-2 (Dab2) expression, suggesting an inverse correlation between Dab2 levels and CP expression/cardiac functional improvement after MSC engraftment. Our investigations further demonstrate that loss of Dab2 expression was sufficient to induce MSC CP expression and improve cardiac function after MSC engraftment after AMI. In summary, we define a novel role for the TGF-β1 receptor adaptor protein Dab2 as a regulator of CP expression in MSCs and its potential as a molecular target for the enhancement of stem cell cardiac specification for transplantation therapies.Keywords
This publication has 54 references indexed in Scilit:
- Mesenchymal stem cell‐based therapy: a new paradigm in regenerative medicineJournal of Cellular and Molecular Medicine, 2009
- Myocardial Regeneration and Stem Cell RepairCurrent Problems in Cardiology, 2008
- Cell-Based Therapy of Myocardial InfarctionArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Exploitation of stem cell homing for gene deliveryExpert Opinion on Biological Therapy, 2007
- SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarctionThe FASEB Journal, 2007
- Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarctCytotherapy, 2007
- Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarctionProceedings of the National Academy of Sciences, 2005
- Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failureProceedings of the National Academy of Sciences, 2005
- Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cellsNature Medicine, 2005
- Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarctionJournal of Clinical Investigation, 2005